Phase 1, Multi-Center, Open-Label Study of VT3989 in Patients with Refractory Locally Advanced or Metastatic Solid Tumors Enriched for Tumors Harboring Mutations of the Neurofibromatosis Type 2 Gene (mutant NF2 or mNF2)

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date20/07/21 → 19/07/26

Keywords

  • phase 1 study
  • treatment safety
  • treatment efficacy
  • solid tumour